Astria Therapeutics Inc [ATXS] stock prices are saw in change for the day to $12.57 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ATXS shares have lost -0.32% over the last week, with a monthly amount glided 4.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astria Therapeutics Inc [NASDAQ: ATXS] stock has seen the most recent analyst activity on November 12, 2025, when Cantor Fitzgerald downgraded its rating to a Neutral. Previously, H.C. Wainwright reaffirmed its Buy rating on September 17, 2025, and elevated its price target to $20. On April 29, 2025, Cantor Fitzgerald initiated with an Overweight rating and assigned a price target of $47 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $26 on January 31, 2025. TD Cowen initiated its recommendation with a Buy and recommended $35 as its price target on July 29, 2024. Evercore ISI started tracking with an Outperform rating for this stock on March 28, 2023, and assigned it a price target of $18.
The stock price of Astria Therapeutics Inc [ATXS] has been fluctuating between $3.56 and $12.72 over the past year. Currently, Wall Street analysts expect the stock to reach $17.33 within the next 12 months. Astria Therapeutics Inc [NASDAQ: ATXS] shares were valued at $12.57 at the most recent close of the market. An investor can expect a potential return of 37.87% based on the average ATXS price forecast.
Analyzing the ATXS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.39 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.46 points at the first support level, and at 12.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.65, and for the 2nd resistance point, it is at 12.73.
Ratios To Look Out For
It’s worth pointing out that Astria Therapeutics Inc [NASDAQ:ATXS]’s Current Ratio is 10.78. Further, the Quick Ratio stands at 10.78, while the Cash Ratio is 4.23. Considering the valuation of this stock, the price to sales ratio is 1010.65, the price to book ratio is 5.14.
